Online ISSN: 2331-4737
www.oncoscience.us
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

LEARN MORE ABOUT ONCOSCIENCE

Behind the Study: Leveraging Scientific Findings to Develop Therapeutic Strategies for Dormant Breast Cancer Cells

Oncoscience

October 4, 2022
Alejandra Ferrer from the Department of Medicine-Hematology/Oncology at Rutgers New Jersey Medical School, describes a recent research perspective she co-authored that was published by Oncoscience, entitled, “Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells.” continue reading »

Oncoscience | As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression

Oncoscience

September 12, 2022
PRESS RELEASE: Dr. Blagosklonny published a new research commentary in Oncoscience, entitled, “As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression.” continue reading »

Oncoscience | SLFN11’s Surveillance Role in Protein Homeostasis

Oncoscience

August 3, 2022
PRESS RELEASE: A new research perspective was published on July 25, 2022, in Volume 9 of Oncoscience, entitled, “SLFN11’s surveillance role in protein homeostasis.” continue reading »

Altos Labs and the Quest for Immortality: Dr. Blagosklonny’s Perspective

News

May 11, 2022
PRESS RELEASE: Mikhail Blagosklonny, M.D., Ph.D., published a new research perspective about upcoming research at Altos Labs. continue reading »